Market Insights Health Hospitals Inpatient Care

Other Inpatient Care - Americas

Americas

In the Americas, the Other Inpatient Care market is anticipated to achieve a remarkable revenue milestone of US$0.42tn by 2024.
This projection sets the stage for a promising future, as the market is expected to exhibit a steady annual growth rate of 2.71% from 2024 to 2029.
By the end of this period, the market volume is estimated to reach US$0.48tn.
When considering the global landscape, it is worth noting that United States will play a significant role in driving revenue generation.
In 2024 alone, United States is projected to contribute a staggering US$349.40bn to the market's overall revenue.
In the Americas, the trend in the market for Other Inpatient Care is a growing demand for specialized medical tourism services in countries like Mexico and Costa Rica.

Key regions: United States, China, India, Japan, Canada

Market

Region

Region comparison

Currency

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.